Agreement signedPublished 3 Sep 2026
Passage Bio, Inc. /
Remix Therapeutics, Inc.
Passage Bio, Inc. signed an agreement for Remix Therapeutics, Inc.
01 / BuyerPassage Bio, Inc.
02 / TargetRemix Therapeutics, Inc.
Source for the buyer and target: Passage Bio, Inc.
For the buyer and target.
“Amended and Restated Agreement and Plan of Merger, dated September 2 , 2026, by and among Passage Bio, Inc., Peregrine Merger Sub, Inc., Peregrine Merger Sub LLC and Remix Therapeutics, Inc.”
Published 3 Sep 2026
Open the sourceWhat happened
The deal for Remix Therapeutics, Inc. is signed, with Passage Bio, Inc. as the buyer. [01]
The filing from Passage Bio, Inc. is dated Sept. 3, 2026. [01]
The source
Everything on this page comes from the source below, quoted word for word.
01
Source · Passage Bio, Inc.
Passage Bio, Inc. signed an agreement for Remix Therapeutics, Inc.
This document is the source for the companies, stage and people on this page.
Open the sourceTimeline
Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Get ProAlready a member? Sign in
Pro is open to everyone.
By email · Weekly